THE Society of Hospital Pharmacists of Australia (SHPA) has set out its plan to strengthen the organisation's Specialty Practice Program.
SHPA CEO, Kristin Michaels, launched the Five Years of Specialty Practice report at the Specialty Practice Leaders Forum yesterday.
"SHPA is proud to launch the report celebrating the last five years of achievement, and strengthening the program for the next five years, not just for hospital pharmacists, but for the entire pharmacy sector," she said.
"Spanning 31 specialties, [the] Specialty Practice has been essential to SHPA's strategic priorities, harnessing and empowering our greatest collective asset, specialised member expertise, to influence policy, regulation and practice, supporting best practice in medicines management to improve health outcomes for Australian patients.
"Specialty Practice has been instrumental in SHPA's role in defining the role of residential aged care pharmacists, achieving changes to the Pharmaceutical Benefits Scheme listing of high-risk opioid analgesics to reduce harm, and providing clinical advice to the Therapeutic Goods Administration on managing complex and critical medicine shortages.
"Ahead of the Jobs and Skills Summit, Health Minister Mark Butler has outlined supporting clinicians throughout their career as one of the new Government's three health workforce priorities.
"SHPA's Specialty Practice program has done exactly that for the pharmacy sector.
"The online Specialty Practice community is a crucial support for pharmacists in their day-to-day practice, working at the coalface in a fragmented healthcare system, and especially so during the uncertainty and demands of the COVID-19 pandemic."
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Sep 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Sep 22
